載入...
Localized Adult Ewing Sarcoma: Favorable Outcomes with Alternating Vincristine, Doxorubicin, Cyclophosphamide, and Ifosfamide, Etoposide (VDC/IE)‐Based Multimodality Therapy
BACKGROUND. In children with localized Ewing sarcoma (ES), addition of ifosfamide and etoposide to cyclophosphamide, doxorubicin, and vincristine (VDC/IE) improved 5‐year overall survival (OS) to 70%–80%. Prior to delivery of VDC/IE in adults, 5‐year OS was <50%. We reviewed our institutional out...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AlphaMed Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5634761/ https://ncbi.nlm.nih.gov/pubmed/28550026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0463 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|